Keyphrases
Acebutolol
11%
Alcohol Intake
11%
Amlodipine
11%
Blood Lipid Profile
22%
Blood Pressure
11%
Blood Pressure Lowering
11%
Cardiovascular Events
11%
Chlorthalidone
11%
Clinical Events
33%
Committee Report
11%
Component Change
11%
Diastolic Blood Pressure
22%
Dietary Sodium Intake
11%
Doxazosin Mesylate
11%
Drug Treatment
100%
Echocardiographic Changes
11%
Electrocardiographic Abnormalities
11%
Electrocardiographic Changes
11%
Enalaprilat
11%
Group Differences
11%
Hypertension Diagnosis
11%
Hypertension Management
11%
Hypertensive Men
11%
Hypertensive Women
11%
Incidence Rate
11%
Initial Dose
11%
Joint National Committee
11%
Large-scale Clinical Trial
11%
Left Ventricular Mass
11%
Lipid Analysis
11%
Maleate
11%
Mild Hypertension
100%
Monotherapy
11%
Non-fatal Cardiovascular Events
11%
One-group
11%
Physical Activity
11%
Placebo
33%
Placebo Groups
33%
Quality of Life
22%
Randomized Placebo-controlled Trial
11%
Screening Center
11%
Serum Components
11%
Systolic Blood Pressure
11%
Treatment Choice
11%
Treatment Facilities
11%
Treatment Group
44%
United States
11%
Medicine and Dentistry
Acebutolol
11%
Alcohol Consumption
11%
Amlodipine Maleate
11%
Antihypertensive Agent
11%
Blood Pressure
11%
Blood Pressure Reduction
11%
Borderline Hypertension
100%
Cardiovascular System
44%
Chlortalidone
11%
Clinical Trial
11%
Controlled Clinical Trial
11%
Diastolic Blood Pressure
22%
Doxazosin Mesylate
11%
Drug Therapy
100%
ECG Abnormality
11%
Enalapril Maleate
11%
Monotherapy
11%
Physical Activity
11%
Placebo
77%
Quality of Life
22%
Side Effect
11%
Sodium Intake
22%
Systolic Blood Pressure
11%
Treatment Group
44%
Nursing and Health Professions
Acebutolol
11%
Alcohol Consumption
11%
Amlodipine Maleate
11%
Antihypertensive Agent
11%
Blood Pressure
22%
Borderline Hypertension
100%
Chlortalidone
11%
Diastolic Blood Pressure
22%
Doxazosin Mesylate
11%
Drug Therapy
100%
ECG Abnormality
11%
Enalapril Maleate
11%
Heart Left Ventricle Mass
11%
Lipid Analysis
11%
Lipid Blood Level
22%
Monotherapy
11%
Placebo
77%
Quality of Life
22%
Side Effect
11%
Sodium Intake
22%
Systolic Blood Pressure
11%
Treatment Centre
11%
Treatment Group
44%
Pharmacology, Toxicology and Pharmaceutical Science
Acebutolol
11%
Amlodipine Maleate
11%
Antihypertensive Agent
11%
Borderline Hypertension
100%
Chlortalidone
11%
Clinical Trial
11%
Controlled Clinical Trial
11%
Doxazosin Mesylate
11%
ECG Abnormality
11%
Enalapril Maleate
11%
Monotherapy
11%
Pharmacotherapy
100%
Placebo
77%
Side Effect
11%
Treatment Group
44%
Neuroscience
Acebutolol
11%
Amlodipine
11%
Antihypertensive Agent
11%
Chlortalidone
11%
Doxazosin
11%
Drug Therapy
100%
Enalapril
11%
Hypertension
100%
Placebo
77%